JP2023513354A5 - - Google Patents

Info

Publication number
JP2023513354A5
JP2023513354A5 JP2022548842A JP2022548842A JP2023513354A5 JP 2023513354 A5 JP2023513354 A5 JP 2023513354A5 JP 2022548842 A JP2022548842 A JP 2022548842A JP 2022548842 A JP2022548842 A JP 2022548842A JP 2023513354 A5 JP2023513354 A5 JP 2023513354A5
Authority
JP
Japan
Prior art keywords
alkyl
unsubstituted
compound according
compound
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022548842A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023513354A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/018042 external-priority patent/WO2021163631A1/en
Publication of JP2023513354A publication Critical patent/JP2023513354A/ja
Publication of JP2023513354A5 publication Critical patent/JP2023513354A5/ja
Priority to JP2025272786A priority Critical patent/JP2026053525A/ja
Pending legal-status Critical Current

Links

JP2022548842A 2020-02-12 2021-02-12 カルパイン-2阻害剤化合物および治療方法 Pending JP2023513354A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025272786A JP2026053525A (ja) 2020-02-12 2025-12-22 カルパイン-2阻害剤化合物および治療方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062975644P 2020-02-12 2020-02-12
US62/975,644 2020-02-12
PCT/US2021/018042 WO2021163631A1 (en) 2020-02-12 2021-02-12 Calpain-2 inhibitor compounds and methods of treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025272786A Division JP2026053525A (ja) 2020-02-12 2025-12-22 カルパイン-2阻害剤化合物および治療方法

Publications (2)

Publication Number Publication Date
JP2023513354A JP2023513354A (ja) 2023-03-30
JP2023513354A5 true JP2023513354A5 (https=) 2024-02-21

Family

ID=77291654

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022548842A Pending JP2023513354A (ja) 2020-02-12 2021-02-12 カルパイン-2阻害剤化合物および治療方法
JP2025272786A Pending JP2026053525A (ja) 2020-02-12 2025-12-22 カルパイン-2阻害剤化合物および治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025272786A Pending JP2026053525A (ja) 2020-02-12 2025-12-22 カルパイン-2阻害剤化合物および治療方法

Country Status (3)

Country Link
US (1) US12606520B2 (https=)
JP (2) JP2023513354A (https=)
WO (1) WO2021163631A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025255171A1 (en) * 2024-06-03 2025-12-11 Western University Of Health Sciences Treatment of neurodegenerative diseases and disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2252310A4 (en) 2008-02-06 2011-09-07 Georgia Tech Res Inst HETEROCYCLIC PEPTIDE KETOAMIDE
WO2016077461A2 (en) * 2014-11-11 2016-05-19 Western University Of Health Sciences Isoform-specific calpain inhibitors, methods of identification, and uses thereof
US20210179543A1 (en) 2018-08-13 2021-06-17 Western University Of Health Sciences Calpain-2 selective inhibitor compounds for treatment of glaucoma

Similar Documents

Publication Publication Date Title
US7750042B2 (en) Paclitaxel enhancer compound
US6395725B1 (en) Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
RU2495044C2 (ru) Ингибиторы активности протеинтирозинкиназы
KR101830244B1 (ko) 신규한 헤테로방향족 고리 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 s1p 수용체 관련 질환의 예방 또는 치료용 약학적 조성물
RU2007101685A (ru) Модуляторы никотиновых ацетилхолиновых рецепторов альфа 7 и их терапевтические применения
US20030195258A1 (en) Taxol enhancer compounds
RU97118591A (ru) Производные ацетамида, способ его получения и содержащие его фармацевтические композиции
RU2000131183A (ru) Производные оксииминоалкановой кислоты
ZA200401051B (en) Taxol enhancer compounds
RU2010100945A (ru) Способы и композиции для стимулирования нейрогенеза и ингибирования дегенерации нейронов с использованием изотиазолопиримидинонов
RU2008139195A (ru) Замещенные арилсульфанамиды как противовирусные средства
JP2023513354A5 (https=)
ZA200300641B (en) Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder.
US20090131377A1 (en) Combinations of Superoxide Dismutase Mimetics and Nonsteroidal Analgesic/Anti-Inflammatory Drugs
KR940702491A (ko) 옥사졸리돈 유도체
JP2023510865A5 (https=)
CA2098593C (en) Treatment method for cancer
JP2024099528A5 (https=)
JP2022521474A5 (https=)
RU2005105058A (ru) Новые производные арилимидазола, их препараты и их терапевтические применения
JPH025735B2 (https=)
KR930703257A (ko) 엔엠디에이(nmda) 길항제
KR900000383A (ko) 신규 화합물
RU2021129954A (ru) Циклические фосфатные соединения
JP3717955B2 (ja) 医薬組成物